Drs. Berrocal Reflect on ASRS 2026 - Report - MDSpire

Drs. Berrocal Reflect on ASRS 2026

ASRS 2026 meeting program chair Audina M. “Nina” Berrocal, MD, FASRS, joins Maria H. Berrocal, MD, to discuss the meeting’s highlights, surgical sessions, and educational approach.

  • By

  • Audina M. Berrocal, MD

  • Maria H. Berrocal, MD

  • July 15, 2026

  • 3 min

Share

Clinical Report: Highlights from ASRS 2026 Meeting

Overview

The ASRS 2026 meeting showcased innovative formats and diverse participation, emphasizing young and female surgeons. Key discussions included surgical techniques.

Background

The American Society of Retina Specialists (ASRS) meeting serves as a pivotal platform for advancements in retinal surgery and education. This year's meeting also aligns with ongoing developments in retinal disease management, particularly in the context of evolving treatment guidelines.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • The ASRS 2026 meeting featured a new format focusing on short talks followed by extensive discussions.
  • Young surgeons from around the world showcased their surgical techniques, highlighting global talent.
  • Increased representation of women in retina was a notable aspect of the meeting.
  • The program emphasized the importance of discussion in enhancing learning outcomes.
  • Dr. Nina Berrocal aimed to refresh the meeting's approach by incorporating diverse perspectives.

Clinical Implications

The innovative format of the ASRS 2026 meeting may influence future educational approaches in surgical training. The emphasis on discussion could enhance knowledge sharing among practitioners, particularly regarding new techniques and treatment strategies.

Conclusion

The ASRS 2026 meeting successfully highlighted the importance of diversity and innovation in retinal surgery education, setting a precedent for future gatherings.

Related Resources & Content

  1. Retinal Physician, 2026 -- What to Expect at ASRS 2026
  2. Retinal Physician, 2026 -- ASRS President Reflects on a Year of Change
  3. Retinal Physician, 2025 -- Video: Surgical Retina Takes Center Stage at ASRS 2025
  4. PMC, 2026 -- ADA Standards of Care
  5. retinal physician — Incoming ASRS President Shares Vision for Future
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC12690177/
  7. https://www.ophthalmologytimes.com/view/asrs-2025-48-month-results-from-oaks-derby-and-gale-open-label-extension
  8. https://pubmed.ncbi.nlm.nih.gov/40876598/?fc=20241210111110&ff=20260121053931&v=2.18.0.post22+67771e2

Original Source(s)

Drs. Berrocal Reflect on ASRS 2026

  • by Audina M. Berrocal, MD, Maria H. Berrocal, MD

  • July 15, 2026

Related Content

The New Rules of Retina Drug Development

In a panel at the Retina Innovation Summit in Montreal, regulatory experts, drug developers, academic advisors, and investors discussed how evolving FDA guidance is reshaping the path from clinical trials to approval.

A First Look at Phase 2 ArMaDa Data

Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.

The Economics of Home OCT

At ASRS 2026, Sean Berkowitz, MD, MBA, examined the payer costs and physician workload associated with home OCT monitoring for wet AMD.